NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (OTCQB: “SCPS”), a biotechnology company developing transformational therapeutics for serious diseases with significant unmet medical need, and its subsidiary, Duet BioTherapeutics Inc., which is developing novel immunotherapies to overcome treatment-resistant cancers, today announced that Marcin Kortylewski, Ph.D., Co-Founder and Senior Scientific Advisor of Duet and Professor of Immuno-Oncology at City of Hope, will be presentin

Related Keywords

California , United States , San Diego , Scopus Biopharma , Marcin Kortylewski , Crescendo Communications , Exchange Commission , Company Form , Scopus Biopharma Inc , Duet Biotherapeutics Inc , Senior Scientific Advisor , Annual Meeting , Tumor Associated Myeloid Cells , Oligonucleotides Sensitizes Malignant Glioma , Board Number , Biopharma , The Company , Biotechnology Company , Mmunotherapies , City Of Hope , Scopus , Poster Board Number ,